US7244396B2
(en)
*
|
1999-04-06 |
2007-07-17 |
Uab Research Foundation |
Method for preparation of microarrays for screening of crystal growth conditions
|
US20030022383A1
(en)
*
|
1999-04-06 |
2003-01-30 |
Uab Research Foundation |
Method for screening crystallization conditions in solution crystal growth
|
US7250305B2
(en)
*
|
2001-07-30 |
2007-07-31 |
Uab Research Foundation |
Use of dye to distinguish salt and protein crystals under microcrystallization conditions
|
US7214540B2
(en)
*
|
1999-04-06 |
2007-05-08 |
Uab Research Foundation |
Method for screening crystallization conditions in solution crystal growth
|
JP3866043B2
(ja)
*
|
1999-04-06 |
2007-01-10 |
ザ ユーエービー リサーチ ファウンデイション |
溶液結晶成長における結晶化条件をスクリーニングする方法
|
US7247490B2
(en)
*
|
1999-04-06 |
2007-07-24 |
Uab Research Foundation |
Method for screening crystallization conditions in solution crystal growth
|
US6630006B2
(en)
*
|
1999-06-18 |
2003-10-07 |
The Regents Of The University Of California |
Method for screening microcrystallizations for crystal formation
|
US6975924B2
(en)
*
|
1999-12-03 |
2005-12-13 |
Baxter International Inc. |
Method and apparatus for controlling the strategy of compounding pharmaceutical admixtures
|
US20050095696A9
(en)
*
|
2000-01-07 |
2005-05-05 |
Lemmo Anthony V. |
Apparatus and method for high-throughput preparation and characterization of compositions
|
US20070021929A1
(en)
*
|
2000-01-07 |
2007-01-25 |
Transform Pharmaceuticals, Inc. |
Computing methods for control of high-throughput experimental processing, digital analysis, and re-arraying comparative samples in computer-designed arrays
|
US6977723B2
(en)
|
2000-01-07 |
2005-12-20 |
Transform Pharmaceuticals, Inc. |
Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
|
US7108970B2
(en)
*
|
2000-01-07 |
2006-09-19 |
Transform Pharmaceuticals, Inc. |
Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
|
US20070020662A1
(en)
*
|
2000-01-07 |
2007-01-25 |
Transform Pharmaceuticals, Inc. |
Computerized control of high-throughput experimental processing and digital analysis of comparative samples for a compound of interest
|
GB0008563D0
(en)
*
|
2000-04-07 |
2000-05-24 |
Cambridge Discovery Chemistry |
Investigating different physical and/or chemical forms of materials
|
EP1172646A1
(en)
*
|
2000-07-13 |
2002-01-16 |
Universiteit Leiden |
Screening crystallisation conditions of organic compounds
|
US20080182293A1
(en)
*
|
2000-07-14 |
2008-07-31 |
Transform Pharmaceuticals, Inc. |
Computerized control of high-throughput transdermal experimental processing and digital analysis of comparative samples
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6607784B2
(en)
*
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6750064B2
(en)
*
|
2000-12-28 |
2004-06-15 |
S.S.C.I. Inc. |
Methods of screening for possible solid forms
|
US7670429B2
(en)
*
|
2001-04-05 |
2010-03-02 |
The California Institute Of Technology |
High throughput screening of crystallization of materials
|
US20060129329A1
(en)
*
|
2001-04-09 |
2006-06-15 |
Kobylecki Ryszard J |
Investigating different physical and/or chemical forms of materials
|
US6733586B2
(en)
|
2001-07-31 |
2004-05-11 |
Illinois Institute Of Technology |
High throughput non-photochemical laser induced nucleation
|
WO2003014732A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Symyx Technologies, Inc. |
Apparatuses and methods for creating and testing pre-formulations and systems for same
|
EP1467205A1
(en)
*
|
2001-08-10 |
2004-10-13 |
Symyx Technologies |
Polymorph characterization
|
WO2003023409A2
(en)
*
|
2001-09-07 |
2003-03-20 |
Transform Pharmaceuticals, Inc. |
Apparatus and method for high-throughput preparation and characterization of compositions
|
JP2005504090A
(ja)
*
|
2001-09-26 |
2005-02-10 |
バクスター・インターナショナル・インコーポレイテッド |
分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
|
JP3759891B2
(ja)
*
|
2001-09-27 |
2006-03-29 |
独立行政法人理化学研究所 |
タンパク質の結晶化方法及び装置
|
EP1308716A1
(en)
*
|
2001-10-03 |
2003-05-07 |
Avantium International B.V. |
Method for performing a transmission diffraction analysis
|
AU2002334987A1
(en)
*
|
2001-10-15 |
2003-04-28 |
The Regents Of The University Of Michigan |
Systems and methods for the generation of crystalline polymorphs
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
US6881363B2
(en)
*
|
2001-12-07 |
2005-04-19 |
Symyx Technologies, Inc. |
High throughput preparation and analysis of materials
|
US6860940B2
(en)
*
|
2002-02-11 |
2005-03-01 |
The Regents Of The University Of California |
Automated macromolecular crystallization screening
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US7790905B2
(en)
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
WO2004061433A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
WO2004078161A1
(en)
*
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
US7446107B2
(en)
|
2002-02-15 |
2008-11-04 |
Transform Pharmaceuticals, Inc. |
Crystalline forms of conazoles and methods of making and using the same
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
US6919556B1
(en)
|
2002-02-22 |
2005-07-19 |
Monocle Technologies, Inc. |
System and method for monitoring and evaluating solid and semi-solid materials
|
AU2003213719A1
(en)
|
2002-03-01 |
2003-09-16 |
Regents Of The University Of Michigan |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
GB0206819D0
(en)
*
|
2002-03-22 |
2002-05-01 |
Univ Glasgow |
A crystallisation system and method
|
US6968037B2
(en)
|
2002-04-10 |
2005-11-22 |
Bristol-Myers Squibb Co. |
High throughput X-ray diffraction filter sample holder
|
US7205413B2
(en)
|
2002-05-03 |
2007-04-17 |
Transform Pharmaceuticals, Inc. |
Solvates and polymorphs of ritonavir and methods of making and using the same
|
CA2484732A1
(en)
*
|
2002-05-07 |
2003-11-20 |
The Research Foundation Of State University Of New York |
A method to rapidly prepare and screen formulations and compositions containing same
|
US20070026528A1
(en)
*
|
2002-05-30 |
2007-02-01 |
Delucas Lawrence J |
Method for screening crystallization conditions in solution crystal growth
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
EP1511490A4
(en)
|
2002-05-31 |
2009-03-11 |
Transform Pharmaceuticals Inc |
NOVEL CONAZOLE CRYSTALLINE FORMS AND RELATED METHODS, PHARMACEUTICAL COMPOSITIONS AND METHODS
|
AU2003237371A1
(en)
*
|
2002-06-05 |
2003-12-22 |
Transform Pharmaceuticals, Inc. |
High-throughput methods and systems for screening of compounds to treat/prevent kidney disorders
|
CA2489984A1
(en)
*
|
2002-06-21 |
2003-12-31 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
AU2003256469A1
(en)
*
|
2002-07-10 |
2004-01-23 |
Uab Research Foundation |
Method for distinguishing between biomolecule and non-biomolecule crystals
|
CA2498043A1
(en)
*
|
2002-08-05 |
2004-07-01 |
Baxter International Inc. |
Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7270952B2
(en)
*
|
2002-09-24 |
2007-09-18 |
Intel Corporation |
Detecting molecular binding by monitoring feedback controlled cantilever deflections
|
US20100210027A9
(en)
*
|
2002-11-04 |
2010-08-19 |
Hongming Chen |
Method for determining effect of preformulation forms on their dissolution rates
|
AU2003287491A1
(en)
*
|
2002-11-04 |
2004-06-07 |
Transform Pharmaceuticals, Inc. |
Preformulation analysis and optimization
|
EP1558907A4
(en)
|
2002-11-04 |
2012-03-21 |
Transform Pharmaceuticals Inc |
METHOD FOR MANIPULATING SMALLER SOLIDS
|
FR2849029B1
(fr)
|
2002-12-20 |
2005-03-18 |
Lafon Labor |
Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
JP5021934B2
(ja)
*
|
2002-12-30 |
2012-09-12 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
改善された溶解性を有する医薬組成物
|
WO2004064762A2
(en)
|
2003-01-21 |
2004-08-05 |
S.S.C.I. Inc. |
Novel cocrystallization
|
CA2514733A1
(en)
*
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
US7024955B2
(en)
*
|
2003-03-01 |
2006-04-11 |
Symyx Technologies, Inc. |
Methods and systems for dissolution testing
|
US6943249B2
(en)
|
2003-03-17 |
2005-09-13 |
Ash Stevens, Inc. |
Methods for isolating crystalline Form I of 5-azacytidine
|
JP2007502329A
(ja)
*
|
2003-05-23 |
2007-02-08 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
セルトラリン組成物
|
US20040241668A1
(en)
*
|
2003-05-30 |
2004-12-02 |
Amorese Douglas A. |
Ligand array assays that include a low surface tension fluid wash step and compositions for practicing the same
|
US20040241880A1
(en)
*
|
2003-05-30 |
2004-12-02 |
Leproust Eric M. |
Ligand array assays having reduced fluorescent dye degradation and compositions for practicing the same
|
US20040241742A1
(en)
*
|
2003-05-30 |
2004-12-02 |
Peck Bill J. |
Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same
|
UA83504C2
(en)
*
|
2003-09-04 |
2008-07-25 |
Селджин Корпорейшн |
Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
US7223761B2
(en)
*
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
EP1667791A1
(en)
*
|
2003-10-06 |
2006-06-14 |
Solvias AG |
Process for the parallel detection of crystalline forms of molecular solids
|
ITMI20032144A1
(it)
*
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
EP1711163A2
(en)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Dispersions prepared by use of self-stabilizing agents
|
US20070173536A1
(en)
*
|
2004-02-06 |
2007-07-26 |
Ciba Specialty Chemicals Holding Inc. |
Crystalline forms of zolmitriptan
|
US20070287194A1
(en)
*
|
2004-03-12 |
2007-12-13 |
S.S.C.I., Inc |
Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound
|
MX2007000428A
(es)
|
2004-07-15 |
2008-03-05 |
Amr Technology Inc |
Tetrahidroisoquinolinas sustituidas con arilo y heteroarilo y uso de las mismas para bloquear la captacion de norepinefrina, dopamina y serotonina.
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
WO2006054964A1
(en)
*
|
2004-11-12 |
2006-05-26 |
Syngenta Limited |
Preparation and characterization of formulations in a high throughput mode
|
US20060140821A1
(en)
*
|
2004-12-17 |
2006-06-29 |
Rosso Victor W |
Powder X-ray diffraction sample holder
|
US20090208919A1
(en)
*
|
2005-01-21 |
2009-08-20 |
Argylla Technologies, Llp |
Particle matrix for storage of biomolecules
|
CN102886045A
(zh)
|
2005-02-03 |
2013-01-23 |
综合医院公司 |
治疗吉非替尼耐药性癌症的方法
|
WO2006114705A1
(en)
*
|
2005-04-27 |
2006-11-02 |
Warner-Lambert Company Llc |
Automated birefringence analysis and targeting system
|
AR057649A1
(es)
*
|
2005-05-27 |
2007-12-12 |
Wyeth Corp |
Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
BRPI0612071A2
(pt)
*
|
2005-06-14 |
2010-10-19 |
Baxter Int |
formulações farmacêuticas para minimizar interações entre fármacos
|
US7722838B2
(en)
*
|
2005-07-19 |
2010-05-25 |
Grahn - Monde Groupe De Reflexion & D'action |
System and device for prevention and neutralization of bioactive substances and generating an aroma-producing substance
|
EP1951235B1
(en)
*
|
2005-09-20 |
2010-03-10 |
Scinopharm Singapore Pte, Ltd. |
Novel crystal forms of irinotecan hydrochloride
|
EP3488866A1
(en)
|
2005-11-04 |
2019-05-29 |
Wyeth LLC |
Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272
|
EP1945632B1
(en)
|
2005-11-08 |
2013-09-18 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic modulators of atp-binding cassette transporters
|
CN101309669A
(zh)
*
|
2005-11-15 |
2008-11-19 |
巴克斯特国际公司 |
脂氧合酶抑制剂的组合物
|
JP5396085B2
(ja)
|
2005-12-14 |
2014-01-22 |
マクテシム・ケミカル・ワークス・リミテツド |
5−アミノ−1−[2,6−ジクロロ−4−(トリフルオロメチル)フェニル]−4−[(トリフルオロメチル)スルフィニル]−1h−ピラゾール−3−カルボニトリルの多形および非晶形
|
GB0525559D0
(en)
*
|
2005-12-15 |
2006-01-25 |
Oxford Diffraction Ltd |
In-situ crystalline material screening apparatus and method
|
GB0601406D0
(en)
*
|
2006-01-24 |
2006-03-08 |
Novartis Ag |
Organic Compounds
|
GB0602778D0
(en)
*
|
2006-02-10 |
2006-03-22 |
Glaxo Group Ltd |
Novel compound
|
US7471386B2
(en)
|
2006-02-27 |
2008-12-30 |
Chemimage Corporation |
System and method for spectral unmixing in a fiber array spectral translator based polymorph screening system
|
US8158957B2
(en)
|
2006-03-02 |
2012-04-17 |
Chemimage Corporation |
System and method for structured illumination and collection for improved optical confocality of raman fiber array spectral translator imaging and interactive raman probing
|
US7629591B2
(en)
*
|
2006-03-02 |
2009-12-08 |
Chemimage Corporation |
System and method for structured illumination and collection for improved optical confocality of raman fiber array spectral translator imaging and interactive raman probing
|
EP1994418A2
(en)
*
|
2006-03-03 |
2008-11-26 |
Chemimage Corporation |
System and method for fiber array spectral translator based polymorph screening
|
US20110009623A1
(en)
*
|
2006-03-20 |
2011-01-13 |
Worcester Polytechnic Institute |
Selective growth of stable polymorphs
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
CA2810522A1
(en)
|
2006-05-04 |
2007-11-15 |
Boehringer Ingelheim International Gmbh |
Polymorphs
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
US7840300B2
(en)
*
|
2006-05-31 |
2010-11-23 |
Robert Arthur Harker |
Full spectrum lapidary 3D image scanner and method
|
CA2658896A1
(en)
*
|
2006-07-25 |
2008-01-31 |
Abbott Laboratories |
Crystalline forms of rapamycin analogs
|
JP2010504314A
(ja)
*
|
2006-09-22 |
2010-02-12 |
シプラ・リミテッド |
リファキシミン
|
EP2066302A2
(en)
*
|
2006-09-26 |
2009-06-10 |
Taro Pharmaceuticals North America, Inc. |
Stabilizing compositions for antibiotics and methods of use
|
EP1923053A1
(en)
|
2006-09-27 |
2008-05-21 |
Novartis AG |
Pharmaceutical compositions comprising nilotinib or its salt
|
MX2009003299A
(es)
*
|
2006-09-28 |
2009-04-09 |
Lundbeck & Co As H |
[2-(6-fluor-1h-indol-3-ilsulfanil)bencil]metilamina para el tratamiento de trastornos afectivos.
|
AR062927A1
(es)
|
2006-10-11 |
2008-12-17 |
Bayer Healthcare Ag |
4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
|
US20090152176A1
(en)
*
|
2006-12-23 |
2009-06-18 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
WO2009002568A2
(en)
*
|
2007-01-16 |
2008-12-31 |
Genvault Corporation |
Nanoparticles useful for biomolecule storage
|
WO2008092116A2
(en)
*
|
2007-01-26 |
2008-07-31 |
Biodot, Inc. |
Non-contact positive dispense solid powder sampling apparatus and method
|
JP4674910B2
(ja)
*
|
2007-03-29 |
2011-04-20 |
セキテクノトロン株式会社 |
ラマン分光法による結晶多形の自動判定方法及びその装置
|
MX2009010761A
(es)
†
|
2007-04-05 |
2009-10-28 |
Pfizer Prod Inc |
Formas cristalinas de 6-[2-(metilcarbamoil)fenilsulfanil]-3-e-[2-( piridin-2-il)etenil]indzol adecuadas para el tratamiento del crecimiento celular anormal en mamiferos.
|
US20090081721A1
(en)
*
|
2007-04-11 |
2009-03-26 |
The Regents Of The University Of California |
High-throughput cell assays
|
US8037945B2
(en)
*
|
2007-04-13 |
2011-10-18 |
Savannah River Nuclear Solutions, Llc |
Atomic force microscope with combined FTIR-Raman spectroscopy having a micro thermal analyzer
|
US8969386B2
(en)
|
2007-05-09 |
2015-03-03 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US20090010388A1
(en)
*
|
2007-06-06 |
2009-01-08 |
Stahly Barbara C |
Microplate and methods of using the same
|
US8018588B2
(en)
*
|
2007-06-06 |
2011-09-13 |
Aptuit, Inc. |
Sample holder and sample preparation device
|
DE102007034854A1
(de)
*
|
2007-07-24 |
2009-01-29 |
Jpk Instruments Ag |
Verfahren und Vorrichtung zur automatisierten Messung und Kombination von Bildaufnahme und Kraftmessung
|
US20090031826A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Dow Global Technologies Inc. |
High-Throughput Sample Preparation and Analysis for Differential Scanning Calorimetry
|
SI2195293T1
(sl)
|
2007-08-22 |
2014-02-28 |
Astrazeneca Ab |
Derivati ciklopropil amida
|
EP2044934A1
(en)
*
|
2007-10-01 |
2009-04-08 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof
|
EP2212327A1
(en)
*
|
2007-10-12 |
2010-08-04 |
Abbott Laboratories |
2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1
|
JP2011500588A
(ja)
*
|
2007-10-12 |
2011-01-06 |
アボット・ラボラトリーズ |
2−((r)−2−メチルピロリジン−2−イル)−1h−ベンズイミダゾール−4−カルボキサミド結晶型2
|
US8022216B2
(en)
*
|
2007-10-17 |
2011-09-20 |
Wyeth Llc |
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
|
WO2009059605A1
(en)
*
|
2007-11-08 |
2009-05-14 |
University Of Copenhagen |
Small scale solid state screening
|
US20090155920A1
(en)
*
|
2007-11-12 |
2009-06-18 |
Symyx Technologies, Inc. |
High throughput dissolution and precipitation apparatus and method
|
RS55360B1
(sr)
|
2007-12-07 |
2017-03-31 |
Vertex Pharma |
Proces za proizvodnju cikloalkilkarboksiamido-piridin benzoevih kiselina
|
CA2706920C
(en)
|
2007-12-07 |
2018-02-13 |
Vertex Pharmaceuticals Incorporated |
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
WO2009083739A1
(en)
*
|
2008-01-01 |
2009-07-09 |
Cipla Limited |
Method of synthesis of bosentan, its polymorphic forms and its salts
|
US8486956B2
(en)
*
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
KR101674382B1
(ko)
|
2008-02-25 |
2016-11-09 |
샐릭스 파마슈티컬스 리미티드 |
리팍시민의 형태 및 이의 용도
|
US20090218489A1
(en)
*
|
2008-02-28 |
2009-09-03 |
Douglas William Akers |
Systems and methods for material treatment and characterization employing positron annihilation
|
JP5523352B2
(ja)
|
2008-02-28 |
2014-06-18 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Cftr修飾因子としてのへテロアリール誘導体
|
BRPI0908731A2
(pt)
*
|
2008-03-17 |
2017-05-16 |
Bial - Portela & C A S A |
formas cristalinas de 5-[3-(2,5-dicloro-4,6-dimetil-1-óxi-piridina-3-il)[1,2,4]oxadiazol-5-il]-3-nitrobenzeno-1,2-diol
|
CA2719246A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Taro Pharmaceuticals North America, Inc. |
Stabilizing lipid compositions for oral pharmaceutical agents
|
MX2010010244A
(es)
*
|
2008-03-27 |
2010-10-05 |
Bristol Myers Squibb Co |
Forma cristalina de n-[[4-fluoro-2-(5-metil-1h-1,2,4-triazol-1-il) fenil]metil]-4,6,7,9-tetrahidro-3-hidroxi-9,9-dimetil-4-oxo-pirim ido[2,1-c][1,4]oxazin-2-carboxamida, sal sodio monohidratada.
|
PE20091730A1
(es)
|
2008-04-03 |
2009-12-10 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
US9156812B2
(en)
|
2008-06-04 |
2015-10-13 |
Bristol-Myers Squibb Company |
Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
|
AR071997A1
(es)
*
|
2008-06-04 |
2010-07-28 |
Bristol Myers Squibb Co |
Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
|
US20090312360A1
(en)
|
2008-06-17 |
2009-12-17 |
Wyeth |
Antineoplastic Combinations Containing HKI-272 and Vinorelbine
|
US20100011889A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Biodot, Inc. |
Handheld powder handling devices and related methods
|
TWI472521B
(zh)
*
|
2008-07-17 |
2015-02-11 |
Lexicon Pharmaceuticals Inc |
(2s,3r,4r,5s,6r)-2-(4-氯-3-(4-乙氧苄基)苯基)-6-(甲硫)四氫-2h-哌喃-3,4,5-三醇的固體形態與其使用方法
|
JP5681108B2
(ja)
|
2008-08-04 |
2015-03-04 |
ワイス・エルエルシー |
4−アニリノ−3−シアノキノリンとカペシタビンの抗新生物薬の組合せ
|
KR20190016601A
(ko)
|
2008-08-06 |
2019-02-18 |
베링거 인겔하임 인터내셔날 게엠베하 |
메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
|
TW201016675A
(en)
*
|
2008-09-16 |
2010-05-01 |
Mitsubishi Tanabe Pharma Corp |
Crystalline benzoimidazole compound and salt thereof
|
MX2011002828A
(es)
*
|
2008-09-16 |
2011-04-05 |
Boehringer Ingelheim Int |
Formas cristalinas de un derivado de 2-tiazolil-4-quinolinil-oxi, un potente inhibidor de hcv.
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
AU2009331471B2
(en)
|
2008-12-23 |
2015-09-03 |
Boehringer Ingelheim International Gmbh |
Salt forms of organic compound
|
JP5289989B2
(ja)
*
|
2009-01-27 |
2013-09-11 |
日本分光株式会社 |
位相差測定装置
|
TW201039825A
(en)
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
CA2755789C
(en)
|
2009-04-06 |
2016-01-19 |
Wyeth Llc |
Treatment regimen utilizing neratinib for breast cancer
|
US9034899B2
(en)
|
2009-05-12 |
2015-05-19 |
Albany Molecular Research, Inc. |
Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
|
US20110066386A1
(en)
*
|
2009-09-16 |
2011-03-17 |
Chien-Chong Hong |
Anesthetic sensing optical microfluidic chip system
|
FR2951171A1
(fr)
*
|
2009-10-09 |
2011-04-15 |
Novexel |
Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
|
BR112012012947B8
(pt)
*
|
2009-11-27 |
2021-05-25 |
Genzyme Corp |
sal de hemitartarato e composição farmacêutica compreendendo o mesmo
|
KR102668834B1
(ko)
|
2009-11-27 |
2024-05-24 |
베링거 인겔하임 인터내셔날 게엠베하 |
리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
|
US20110201622A1
(en)
*
|
2010-02-18 |
2011-08-18 |
Collins Craig D |
Solid Forms Comprising A Cyclopropyl Amide Derivative
|
KR20130004296A
(ko)
*
|
2010-02-18 |
2013-01-09 |
아스트라제네카 아베 |
시클로프로필 아미드 유도체의 제조 방법 및 그와 관련된 중간체
|
GB201004677D0
(en)
*
|
2010-03-19 |
2010-05-05 |
Vantia Ltd |
New salt
|
NZ602578A
(en)
*
|
2010-03-23 |
2014-08-29 |
Siga Technologies Inc |
Polymorphic forms st-246 and methods of preparation
|
BR112012026255A2
(pt)
|
2010-04-07 |
2017-03-14 |
Vertex Pharma |
composições farmacêuticas de ácido 3-(6-(1-(2-,2-difluorbenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzóico e administração das mesmas
|
CN102946875A
(zh)
|
2010-05-05 |
2013-02-27 |
贝林格尔.英格海姆国际有限公司 |
组合疗法
|
WO2011156061A1
(en)
*
|
2010-06-07 |
2011-12-15 |
Telik, Inc. |
Preparation of crystalline ezatiostat hydrochloride ansolvate form d
|
NZ603319A
(en)
|
2010-06-24 |
2015-04-24 |
Boehringer Ingelheim Int |
Diabetes therapy
|
JP5780721B2
(ja)
*
|
2010-08-06 |
2015-09-16 |
日京テクノス株式会社 |
タンパク質結晶成長装置、及びその方法
|
AR082804A1
(es)
*
|
2010-09-01 |
2013-01-09 |
Portola Pharm Inc |
Formas cristalinas de un inhibidor del factor xa
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
JP2013544271A
(ja)
*
|
2010-12-03 |
2013-12-12 |
ポートラ ファーマシューティカルズ, インコーポレイテッド |
式(i)の化合物の薬学的組成物、投薬形態、および新規の形態、ならびにその使用方法
|
TWI530489B
(zh)
*
|
2011-03-22 |
2016-04-21 |
必治妥美雅史谷比公司 |
雙(氟烷基)-1,4-苯二氮呯酮化合物
|
DE102011103751A1
(de)
*
|
2011-05-31 |
2012-12-06 |
Heraeus Precious Metals Gmbh & Co. Kg |
Kristallisierung von Epirubicinhydrochlorid
|
PL2722331T3
(pl)
*
|
2011-06-16 |
2018-02-28 |
Mitsubishi Gas Chemical Company, Inc. |
Kryształ soli disodowej pirolochinolinochinonu oraz sposób jego wytwarzania
|
JP2014518236A
(ja)
*
|
2011-07-08 |
2014-07-28 |
サノフイ |
6−(ピペリジン−4−イルオキシ)−2h−イソキノリン−1−オン塩酸塩の多形体
|
PL2729460T3
(pl)
*
|
2011-07-08 |
2016-07-29 |
Sanofi Sa |
Krystaliczne solwaty chlorowodorku 6-(piperydyn-4-ylooksy)-2H-izochinolin-1-onu
|
US8962636B2
(en)
|
2011-07-15 |
2015-02-24 |
Boehringer Ingelheim International Gmbh |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
ES2587847T3
(es)
*
|
2011-07-29 |
2016-10-27 |
Medicinova, Inc. |
Di-hidrocloruro de denibulina
|
US9594008B2
(en)
*
|
2012-01-17 |
2017-03-14 |
The Scripps Research Institute |
Preparation of specimen arrays on an EM grid
|
DK2807178T3
(en)
*
|
2012-01-26 |
2017-09-04 |
Inotek Pharmaceuticals Corp |
Anhydrous polymorphs of (2R, 3S, 4R, 5R) -5- (6- (cyclopentylamino) -9H-purin-9-yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl nitrate and processes for their preparation
|
CN106146506A
(zh)
|
2012-03-05 |
2016-11-23 |
吉利德卡利斯托加公司 |
(s)‑2‑(1‑(9h‑嘌呤‑6‑基氨基)丙基)‑5‑氟‑3‑苯基喹唑啉‑4(3h)‑酮的多晶型物
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
CN103360450B
(zh)
*
|
2012-04-01 |
2016-05-11 |
浙江海正药业股份有限公司 |
人参皂苷c-k的两种晶型及其制备方法
|
CN103360441B
(zh)
|
2012-04-01 |
2016-08-10 |
浙江海正药业股份有限公司 |
人参皂苷c-k化合物多晶型及其制备方法
|
EP3685839A1
(en)
|
2012-05-14 |
2020-07-29 |
Boehringer Ingelheim International GmbH |
Linagliptin for use in the treatment of albuminuria and kidney related diseases
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
US9056860B2
(en)
*
|
2012-06-05 |
2015-06-16 |
Gilead Pharmasset Llc |
Synthesis of antiviral compound
|
CN103539783A
(zh)
*
|
2012-07-12 |
2014-01-29 |
江苏恒瑞医药股份有限公司 |
一种酪氨酸激酶抑制剂的二马来酸盐的i型结晶及制备方法
|
US9469673B2
(en)
*
|
2012-07-12 |
2016-10-18 |
Abbvie Inc. |
Crystaline forms of HCV inhibitor
|
CN102746258B
(zh)
|
2012-07-25 |
2015-02-04 |
重庆泰濠制药有限公司 |
卡巴他赛的结晶形式及其制备方法
|
CN104411700B
(zh)
|
2012-07-25 |
2016-06-15 |
株式会社富士药品 |
4-[5-(吡啶-4-基)-1h-1,2,4-三唑-3-基]吡啶-2-腈的多晶型及其制造方法
|
CA2902711C
(en)
|
2013-03-15 |
2021-07-06 |
Global Blood Therapeutics, Inc. |
Substituted pyridinyl-6-methoxy-2-hydroxybenzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
KR20190041548A
(ko)
|
2013-03-15 |
2019-04-22 |
글로벌 블러드 테라퓨틱스, 인크. |
헤모글로빈 조정을 위한 화합물 및 이의 용도
|
CN105073728A
(zh)
|
2013-03-15 |
2015-11-18 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
EP2985277B1
(en)
*
|
2013-04-10 |
2018-01-17 |
Daiichi Sankyo Company, Limited |
Method for preparing an atropisomer of a pyrrole derivative
|
CA2914854C
(en)
*
|
2013-06-09 |
2017-08-22 |
Betta Pharmaceuticals Co., Ltd |
Polymorph forms of icotinib maleate and uses thereof
|
US9688687B2
(en)
|
2013-06-09 |
2017-06-27 |
Betta Pharmaceuticals Co., Ltd. |
Polymorphic forms of icotinib phosphate and uses thereof
|
KR20150001936A
(ko)
*
|
2013-06-28 |
2015-01-07 |
제일약품주식회사 |
게피티닙의 신규한 결정형 및 이의 제조방법
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
DE202013103650U1
(de)
|
2013-08-12 |
2013-09-23 |
Aspect Imaging Ltd. |
Nichtinvasives MRT-System zur Analyse der Qualität von festen Nahrungsmittelprodukten, die von einem flexiblen Aluminiumfolienumschlag umhüllt sind
|
JP5680161B1
(ja)
|
2013-09-06 |
2015-03-04 |
株式会社ポーラファルマ |
晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
|
EP3068779A4
(en)
*
|
2013-11-11 |
2017-06-28 |
Crystal Pharmatech Co. Ltd. |
Crystalline forms b, c, and d of canagliflozin
|
PT3068392T
(pt)
|
2013-11-12 |
2021-05-14 |
Vertex Pharma |
Processo de preparação de composições farmacêuticas para o tratamento de doenças mediadas por condutância transmembrana da fibrose quística (cftr)
|
MA39033A1
(fr)
|
2013-11-15 |
2017-11-30 |
Akebia Therapeutics Inc |
Formes solides d'acide {[5-(3-chlorophényl)-3-hydroxypyridine-2-carbonyl] amino}acétique, compositions et leurs utilisations
|
AU2014364414A1
(en)
|
2013-12-20 |
2016-06-30 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
|
CA2934531C
(en)
|
2013-12-20 |
2020-02-25 |
Gilead Calistoga Llc |
Process methods for phosphatidylinositol 3-kinase inhibitors
|
PE20160179A1
(es)
*
|
2014-02-07 |
2016-05-20 |
Global Blood Therapeutics Inc |
Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metoxi)benzaldehido
|
JPWO2015129603A1
(ja)
*
|
2014-02-25 |
2017-03-30 |
第一三共株式会社 |
活性化血液凝固第X因子(FXa)阻害剤の高純度結晶
|
ES2950384T3
(es)
|
2014-02-28 |
2023-10-09 |
Boehringer Ingelheim Int |
Uso médico de un inhibidor de DPP-4
|
WO2015183801A1
(en)
|
2014-05-27 |
2015-12-03 |
R. J. Reynolds Tobacco Company |
Nicotine salts, co-crystals, and salt co-crystal complexes
|
US10508096B2
(en)
|
2014-05-27 |
2019-12-17 |
R.J. Reynolds Tobacco Company |
Nicotine salts, co-crystals, and salt co-crystal complexes
|
US9896429B2
(en)
|
2014-05-27 |
2018-02-20 |
R.J. Reynolds Tobacco Company |
Nicotine salts, co-crystals, and salt co-crystal complexes
|
US11300531B2
(en)
|
2014-06-25 |
2022-04-12 |
Aspect Ai Ltd. |
Accurate water cut measurement
|
US9687484B2
(en)
|
2014-07-18 |
2017-06-27 |
Dipharma Francis S.R.L. |
Crystalline forms of an antidepressant compound
|
CN105399771B
(zh)
*
|
2014-07-21 |
2020-11-24 |
江苏豪森药业集团有限公司 |
替诺福韦前药晶型及其制备方法和用途
|
JP6734860B2
(ja)
|
2014-11-06 |
2020-08-05 |
リソソーマル・セラピューティクス・インコーポレイテッドLysosomal Therapeutics Inc. |
置換ピラゾロ[1,5−a]ピリミジンおよび医療疾患の治療におけるその使用
|
BR112017010406B1
(pt)
|
2014-11-18 |
2021-03-09 |
Vertex Pharmaceuticals Incorporated |
processo de realização de teste de alta produtividade de cromatografia líquida de alta eficiência
|
SG11201704791WA
(en)
*
|
2014-12-16 |
2017-07-28 |
Celgene Corp |
Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof
|
US10202363B2
(en)
*
|
2014-12-23 |
2019-02-12 |
Cerecor, Inc. |
Compounds, compositions and methods
|
JP6428414B2
(ja)
*
|
2015-03-19 |
2018-11-28 |
株式会社島津製作所 |
オートサンプラ
|
CN105693699B
(zh)
*
|
2015-03-30 |
2019-06-18 |
苏州晶云药物科技股份有限公司 |
托吡司他的晶型及其制备方法
|
PT108370B
(pt)
*
|
2015-03-30 |
2018-10-25 |
Hovione Farm S A |
Processo de preparação de brometo de aclidínio
|
US10702517B2
(en)
|
2015-04-22 |
2020-07-07 |
Celgene Quanticel Research, Inc. |
Bromodomain inhibitor
|
AU2016307256B2
(en)
*
|
2015-08-10 |
2020-11-19 |
Sandoz Ag |
Form C of avibactam sodium
|
JP6684557B2
(ja)
*
|
2015-08-28 |
2020-04-22 |
国立研究開発法人産業技術総合研究所 |
ナノ粒子のスクリーニング方法及びスクリーニングシステム
|
CN108291872A
(zh)
*
|
2015-08-28 |
2018-07-17 |
国立研究开发法人产业技术综合研究所 |
纳米粒子的筛选方法及筛选系统、与纳米粒子及其制造方法
|
JP6651310B2
(ja)
*
|
2015-08-28 |
2020-02-19 |
国立研究開発法人産業技術総合研究所 |
ナノ粒子及びその製造方法
|
CN108495563B
(zh)
|
2015-11-25 |
2022-04-26 |
R.J.雷诺兹烟草公司 |
烟碱盐、共晶体和盐共晶体配合物
|
TW201731509A
(zh)
|
2015-12-04 |
2017-09-16 |
全球血液治療公司 |
針對2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之劑量方案
|
CN106928218B
(zh)
*
|
2015-12-29 |
2021-08-03 |
上海医药集团股份有限公司 |
吗啉衍生物的盐及其晶型、其制备方法及药物组合物、用途
|
US20170275330A1
(en)
*
|
2016-03-28 |
2017-09-28 |
Warsaw Orthopedic, Inc. |
Polymorphic forms of an oxysterol and methods of making them
|
AU2017261291C1
(en)
|
2016-05-05 |
2022-05-26 |
Bial - R&D Investments, S.A. |
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders
|
RU2621187C1
(ru)
*
|
2016-05-13 |
2017-06-01 |
Общество с ограниченной ответственностью "Молекулярные Технологии" |
Новая кристаллическая солевая форма 2,2-диметил-6-((4-((3,4,5-триметоксифенил)амино)-1,3,5-триазин-2-ил)амино)-2н-пиридо[3,2-в][1,4]оксазин-3(4н)-она для медицинского применения
|
MX2018015089A
(es)
|
2016-06-10 |
2019-05-13 |
Boehringer Ingelheim Int |
Combinacion de linagliptina y metformina.
|
JP6676491B2
(ja)
*
|
2016-07-13 |
2020-04-08 |
株式会社トクヤマ |
アジルサルタンアルキルエステルの製造方法、及びアジルサルタンの製造方法
|
CN109415327A
(zh)
*
|
2016-07-05 |
2019-03-01 |
株式会社德山 |
阿齐沙坦中间体、阿齐沙坦及它们的制造方法
|
EP3273239A1
(en)
*
|
2016-07-19 |
2018-01-24 |
Laboratorios Farmacéuticos Rovi, S.A. |
Procedure of analysis of glycosaminoglycans, heparins and their derivatives by nuclear magnetic resonance
|
EP3504189A1
(en)
|
2016-08-23 |
2019-07-03 |
Sage Therapeutics, Inc. |
A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid
|
WO2018036539A1
(zh)
*
|
2016-08-25 |
2018-03-01 |
正大天晴药业集团股份有限公司 |
喹唑啉衍生物的盐的晶体
|
AU2017345468B2
(en)
*
|
2016-10-20 |
2022-06-02 |
Celgene Quanticel Research, Inc. |
Bromodomain inhibitor
|
US11384114B2
(en)
*
|
2016-12-09 |
2022-07-12 |
Warsaw Orthopedic, Inc. |
Polymorphic forms of an oxysterol and methods of making them
|
CN110139904A
(zh)
*
|
2016-12-30 |
2019-08-16 |
涂层国外知识产权有限公司 |
用于配方信息生成的系统和方法
|
CN106770400B
(zh)
*
|
2017-01-06 |
2023-08-15 |
中国工程物理研究院核物理与化学研究所 |
一种用于小角中子散射谱仪的自动换样装置
|
EP3575293B1
(en)
|
2017-01-26 |
2021-03-10 |
ONO Pharmaceutical Co., Ltd. |
Ethanesulfonate salt of n-{5-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-pyridinyl}-2,5-dioxo-1-phenyl-1,2,5,6,7,8-hexahydro-3-quinolinecarboxamide
|
CN116730920A
(zh)
|
2017-02-17 |
2023-09-12 |
文涵治疗有限公司 |
Ag-10的制备方法、其中间体及其盐
|
US10345251B2
(en)
|
2017-02-23 |
2019-07-09 |
Aspect Imaging Ltd. |
Portable NMR device for detecting an oil concentration in water
|
CN106990075B
(zh)
*
|
2017-03-03 |
2019-07-09 |
西北大学 |
一种用于单个悬浮颗粒的二次谐波成像方法和装置
|
US10625233B2
(en)
*
|
2017-04-04 |
2020-04-21 |
Tannas Company |
Testing pharmaceuticals and related substances
|
KR101856444B1
(ko)
|
2017-04-20 |
2018-05-10 |
압타바이오 주식회사 |
3-페닐-4-프로필-1-(피리딘-2-일)-1h-피라졸-5-올 염산염의 신규 결정형 고체 화합물
|
AU2018291026B2
(en)
*
|
2017-06-29 |
2022-09-01 |
G1 Therapeutics, Inc. |
Morphic forms of GIT38 and methods of manufacture thereof
|
US11014907B2
(en)
*
|
2017-08-21 |
2021-05-25 |
Dishman Carbogen Amcis Ltd. |
Octendidine based compounds
|
WO2019049049A1
(en)
|
2017-09-05 |
2019-03-14 |
R. J. Reynolds Tobacco Company |
SALTS, CO-CRYSTALS, AND CO-CRYSTAL COMPLEXES OF NICOTINE SALTS
|
EP3682884B1
(en)
*
|
2017-09-15 |
2024-04-24 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Crystalline forms of daprodustat (gsk1278863), a peroral hypoxia-inducible factor prolyl hydroxylase inhibitor (hif-phi) for treating anemia, and their preparation methods
|
US11826363B2
(en)
|
2017-10-13 |
2023-11-28 |
Ono Pharmaceutical Co., Ltd. |
Therapeutic agent for solid cancers, which comprises Axl inhibitor as active ingredient
|
WO2019113084A1
(en)
*
|
2017-12-05 |
2019-06-13 |
Sunovion Pharmaceuticals Inc. |
Crystal forms and production methods thereof
|
WO2019125967A1
(en)
*
|
2017-12-20 |
2019-06-27 |
Sunshine Lake Pharma Co., Ltd. |
Salts of pyrazolo[1,5-a]pyridine derivative and use thereof
|
US20200339587A1
(en)
*
|
2017-12-21 |
2020-10-29 |
Lysosomal Therapeutics Inc. |
Crystalline substituted cyclohexyl pyrazolo[1,5-a]pyrimidinyl carboxamide compound and therapeutic uses thereof
|
WO2019166012A1
(zh)
*
|
2018-03-02 |
2019-09-06 |
正大天晴药业集团股份有限公司 |
作为c-Met激酶抑制剂的化合物的结晶及其制备方法和用途
|
AU2019236369B2
(en)
|
2018-03-15 |
2024-04-18 |
Bayer Aktiengesellschaft |
Preparative process of two 4-{[(2S)-2-{4-[5-chloro-2-(1H-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2H)-yl}butanoyl]amino}-2-fluorobenzamide derivatives
|
US20210018482A1
(en)
*
|
2018-03-19 |
2021-01-21 |
Trustees Of Boston University |
Systems, devices, and methods for ultrasonic agitation mediated kinetic release testing of compounds
|
BR112020023107A2
(pt)
*
|
2018-05-14 |
2021-02-02 |
Ariad Pharmaceuticals, Inc. |
sais farmacêuticos de derivados de pirimidina e método de tratamento de distúrbios
|
CA3104395A1
(en)
*
|
2018-07-04 |
2020-01-09 |
Radius Pharmaceuticals, Inc. |
Polymorphic forms of rad1901-2hcl
|
CN112533894A
(zh)
*
|
2018-07-25 |
2021-03-19 |
奥赖恩公司 |
4,5-二羟基-2-(4-甲基苄基)异邻苯二甲腈溶剂化物及其结晶形式
|
CN112714762A
(zh)
|
2018-08-06 |
2021-04-27 |
奥尔德拉医疗公司 |
多晶型化合物及其用途
|
WO2020035546A1
(en)
*
|
2018-08-14 |
2020-02-20 |
Nuformix Technologies Limited |
Crystalline tranilast salts and their pharmaceutical use
|
KR20210046708A
(ko)
|
2018-08-17 |
2021-04-28 |
에이도스 테라퓨틱스, 인코포레이티드 |
Ag10의 제형
|
BR112021005290A2
(pt)
*
|
2018-09-26 |
2021-06-22 |
Astrocyte Pharmaceuticals, Inc. |
compostos polimórficos e usos dos mesmos
|
WO2020072377A1
(en)
|
2018-10-01 |
2020-04-09 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin for the treatment of sickle cell disease
|
US11926036B2
(en)
|
2018-10-03 |
2024-03-12 |
Sony Corporation |
Information processing device and scheduling method
|
TW202028208A
(zh)
|
2018-10-09 |
2020-08-01 |
瑞士商諾華公司 |
N-(4-氟-3-(6-(3-甲基吡啶-2-基)-[1,2,4]三唑并[1,5-a]嘧啶-2-基)苯基)-2,4-二甲基㗁唑-5-甲醯胺固體形式
|
CN112840209A
(zh)
*
|
2018-10-15 |
2021-05-25 |
株式会社岛津制作所 |
色谱仪控制装置、色谱仪系统、色谱仪控制方法以及色谱仪控制程序
|
KR20210079317A
(ko)
*
|
2018-10-19 |
2021-06-29 |
에프. 호프만-라 로슈 아게 |
피리도[1,2-a]피리미딘-4-온 유도체의 형태, 그의 제형 및 그의 제조 방법
|
JP7201263B2
(ja)
*
|
2018-11-01 |
2023-01-10 |
ヤマサ醤油株式会社 |
Cyclic-di-AMPナトリウム塩結晶
|
CN109613151A
(zh)
*
|
2018-11-14 |
2019-04-12 |
温州科技职业学院 |
一种检测固态肥料中生长调节剂的预处理方法以及检测液态肥料中生长调节剂的预处理方法
|
MX2021006544A
(es)
*
|
2018-12-04 |
2021-07-07 |
Sumitomo Pharma Oncology Inc |
Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer.
|
CN111285862A
(zh)
*
|
2018-12-07 |
2020-06-16 |
江苏恩华药业股份有限公司 |
一种丙酰胺类衍生物的结晶形式及其制备方法
|
CN109685157A
(zh)
*
|
2019-01-02 |
2019-04-26 |
辽宁工程技术大学 |
一种对结构面产状进行分组的方法
|
JP2022517610A
(ja)
*
|
2019-01-10 |
2022-03-09 |
シーエスピーシー ゾンチー ファーマシューティカル テクノロジー(シージアチュアン)カンパニー,リミテッド |
複素環化合物塩およびその使用
|
JP7451538B2
(ja)
*
|
2019-01-11 |
2024-03-18 |
▲ユ▼展新藥生技股分有限公司 |
ケタミンパモエート及びその使用
|
CN111454318A
(zh)
*
|
2019-01-20 |
2020-07-28 |
浙江易众化工有限公司 |
抗抑郁药物sage-217的晶型及其制备方法
|
AU2020271908A1
(en)
*
|
2019-04-11 |
2021-11-04 |
Mei Pharma, Inc. |
Voruciclib poly morphs and methods of making and using thereof
|
RU2712766C1
(ru)
*
|
2019-04-17 |
2020-01-31 |
федеральное государственное автономное образовательное учреждение высшего образования "Южный федеральный университет" (Южный федеральный университет) |
Способ оценки влияния адсорбирующихся газов на поверхность материалов
|
TW202110823A
(zh)
*
|
2019-05-16 |
2021-03-16 |
瑞士商諾華公司 |
N-[4-(氯二氟甲氧基)苯基]-6-[(3r)-3-羥基吡咯啶-1-基]-5-(1h-吡唑-5-基)吡啶-3-甲醯胺之結晶形狀
|
WO2020238733A1
(zh)
*
|
2019-05-24 |
2020-12-03 |
浙江海正药业股份有限公司 |
丙烯酸类衍生物的晶型及其制备方法和用途
|
CA3142444A1
(en)
|
2019-06-06 |
2020-12-10 |
Genfleet Therapeutics (Shanghai) Inc. |
Polymorph of cdk9 inhibitor and preparation method for polymorph and use thereof
|
EP3992192A4
(en)
*
|
2019-07-22 |
2022-08-17 |
Guangdong Raynovent Biotech Co., Ltd. |
DOMINANT SALT FORMS OF PYRIMIDINE DERIVATIVES AND CRYSTAL FORMS THEREOF
|
CN112345486B
(zh)
*
|
2019-08-08 |
2022-06-14 |
湖南中烟工业有限责任公司 |
一种基于近红外光谱技术的单体香原料溶液所用溶剂的判定方法
|
US11524939B2
(en)
|
2019-11-13 |
2022-12-13 |
Akebia Therapeutics, Inc. |
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
|
JP7410693B2
(ja)
*
|
2019-11-18 |
2024-01-10 |
花王株式会社 |
ベースメイク塗膜の解析方法
|
CN111455455A
(zh)
*
|
2020-02-29 |
2020-07-28 |
武汉大学 |
具有在线监测功能的晶体生长装置
|
CN111323382B
(zh)
*
|
2020-03-23 |
2023-03-14 |
巴彦淖尔市医院 |
一种前列腺癌治疗药剂的鉴别装备及其方法
|
CN112466413B
(zh)
*
|
2020-12-04 |
2024-04-12 |
南通海智医药科技有限公司 |
小分子药物特定晶形的分子调控方法
|
CN112733137B
(zh)
*
|
2020-12-24 |
2021-11-16 |
哈尔滨工业大学 |
一种面向漏洞检测的二进制代码相似性分析方法
|
WO2023204303A1
(ja)
*
|
2022-04-22 |
2023-10-26 |
大鵬薬品工業株式会社 |
7H-ピロロ[2,3-d]ピリミジン-4-アミン誘導体の結晶
|